NASDAQ:ESTA

Establishment Labs Holdings Stock News

Healthcare > Medical - Devices

Buy ESTA

*Your capital is at risk

$72.41

+2.00 (+2.84%)

At Close: Jun 03, 2026

Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

08:00am, Monday, 12'th Jan 2026

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and

Contrasting Establishment Labs (NASDAQ:ESTA) and Tauriga Sciences (OTCMKTS:TAUG)

01:29am, Wednesday, 07'th Jan 2026

Establishment Labs (NASDAQ: ESTA - Get Free Report) and Tauriga Sciences (OTCMKTS:TAUG - Get Free Report) are both medical companies, but which is the superior business? We will compare the two compan

Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference

08:00am, Wednesday, 31'st Dec 2025

ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction

01:45pm, Tuesday, 30'th Dec 2025

Establishment Labs files Motiva breast implants with the FDA for reconstruction, targeting expansion beyond elective augmentation into a clinically necessary market.

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

08:00am, Monday, 29'th Dec 2025

Analyzing Omada Health (NASDAQ:OMDA) & Establishment Labs (NASDAQ:ESTA)

01:12am, Monday, 29'th Dec 2025

Establishment Labs (NASDAQ: ESTA - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based

Financial Contrast: Establishment Labs (NASDAQ:ESTA) & XWELL (NASDAQ:XWEL)

02:30am, Sunday, 21'st Dec 2025

XWELL (NASDAQ: XWEL - Get Free Report) and Establishment Labs (NASDAQ: ESTA - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Recommendation of “Moderate Buy” from Analysts

01:21am, Tuesday, 25'th Nov 2025

Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight research firms that are covering the firm, MarketB

Establishment Labs to Present at Jefferies London Healthcare Conference

08:00am, Friday, 07'th Nov 2025

Establishment Labs Holdings Inc. (ESTA) Q3 2025 Earnings Call Transcript

12:01pm, Wednesday, 05'th Nov 2025

Establishment Labs Holdings Inc. ( ESTA ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Rajbir Denhoy - Chief Financial Officer Filippo Caldini - CEO & Director Conference Ca

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates

10:16am, Wednesday, 05'th Nov 2025

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.59 per share a year ago.

Establishment Labs Reports Third Quarter 2025 Financial Results

08:00am, Wednesday, 05'th Nov 2025

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Given Consensus Rating of “Moderate Buy” by Analysts

01:40am, Friday, 31'st Oct 2025

Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the company

Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5

08:00am, Wednesday, 22'nd Oct 2025

Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal

08:00am, Tuesday, 14'th Oct 2025

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by